Literature DB >> 31622854

Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors.

Wenchao Lu1, Jun Wang2, Yong Li3, Hongru Tao4, Huan Xiong5, Fulin Lian6, Jing Gao7, Hongna Ma8, Tian Lu2, Dan Zhang9, Xiaoqing Ye10, Hong Ding11, Liyan Yue11, Yuanyuan Zhang11, Huanyu Tang3, Naixia Zhang6, Yaxi Yang3, Hualiang Jiang12, Kaixian Chen13, Bing Zhou14, Cheng Luo15.   

Abstract

Transcriptional enhancer associated domain family members (TEADs) are the most important downstream effectors that play the pivotal role in the development, regeneration and tissue homeostasis. Recent biochemical studies have demonstrated that TEADs could undergo autopalmitoylation that is indispensable for its function making the lipid-binding pocket an attractive target for chemical intervention. Herein, through structure-based virtual screen and rational medicinal chemistry optimization, we identified DC-TEADin02 as the most potent, selective, covalent TEAD autopalmitoylation inhibitor with the IC50 value of 197 ± 19 nM while it showed minimal effect on TEAD-YAP interaction. Further biochemical counter-screens demonstrate the specific thiol reactivity and selectivity of DC-TEADin02 over the kinase family, lipid-binding proteins and epigenetic targets. Notably, DC-TEADin02 inhibited TEADs transcription activity leading to downregulation of YAP-related downstream gene expression. Taken together, our findings proved the validity of modulating transcriptional output in the Hippo signaling pathway through irreversible chemical interventions of TEADs autopalmitoylation activity, which may serve as a qualified chemical tool for TEADs palmitoylation-related studies in the future.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Covalent inhibitor; Hippo pathway; Palmitoylation inhibitor; TEAD transcription factor

Mesh:

Substances:

Year:  2019        PMID: 31622854     DOI: 10.1016/j.ejmech.2019.111767

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  11 in total

1.  The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.

Authors:  Ayumi Kaneda; Toshihiro Seike; Tomohiro Danjo; Takahiro Nakajima; Nobumasa Otsubo; Daisuke Yamaguchi; Yoshiro Tsuji; Kaori Hamaguchi; Mai Yasunaga; Yoichi Nishiya; Michihiko Suzuki; Jun-Ichi Saito; Rie Yatsunami; Satoshi Nakamura; Yoshitaka Sekido; Kiyotoshi Mori
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 2.  Hippo in Gastric Cancer: From Signalling to Therapy.

Authors:  Lornella Seeneevassen; Pierre Dubus; Caroline Gronnier; Christine Varon
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

3.  Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma.

Authors:  Jacquelyn T Saunders; Brent Holmes; Angelica Benavides-Serrato; Sunil Kumar; Robert N Nishimura; Joseph Gera
Journal:  J Neurooncol       Date:  2021-01-28       Impact factor: 4.130

4.  Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket.

Authors:  Hacer Karatas; Mohammad Akbarzadeh; Hélène Adihou; Gernot Hahne; Ajaybabu V Pobbati; Elizabeth Yihui Ng; Stéphanie M Guéret; Sonja Sievers; Axel Pahl; Malte Metz; Sarah Zinken; Lara Dötsch; Christine Nowak; Sasikala Thavam; Alexandra Friese; CongBao Kang; Wanjin Hong; Herbert Waldmann
Journal:  J Med Chem       Date:  2020-10-01       Impact factor: 7.446

5.  Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library.

Authors:  Angela Lauriola; Elisa Uliassi; Matteo Santucci; Maria Laura Bolognesi; Marco Mor; Laura Scalvini; Gian Marco Elisi; Gaia Gozzi; Lorenzo Tagliazucchi; Gaetano Marverti; Stefania Ferrari; Lorena Losi; Domenico D'Arca; Maria Paola Costi
Journal:  Pharmaceutics       Date:  2022-02-10       Impact factor: 6.321

Review 6.  Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine.

Authors:  Evan R Barry; Vladimir Simov; Iris Valtingojer; Olivier Venier
Journal:  Cells       Date:  2021-10-11       Impact factor: 6.600

Review 7.  Insights into auto-S-fatty acylation: targets, druggability, and inhibitors.

Authors:  Lu Hu; Zhipeng Tao; Xu Wu
Journal:  RSC Chem Biol       Date:  2021-08-25

Review 8.  Lipid-induced S-palmitoylation as a Vital Regulator of Cell Signaling and Disease Development.

Authors:  Mengyuan Qu; Xuan Zhou; Xiaotong Wang; Honggang Li
Journal:  Int J Biol Sci       Date:  2021-10-11       Impact factor: 6.580

Review 9.  A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy.

Authors:  Ajaybabu V Pobbati; Wanjin Hong
Journal:  Theranostics       Date:  2020-02-18       Impact factor: 11.556

10.  The role of lysine palmitoylation/myristoylation in the function of the TEAD transcription factors.

Authors:  Yannick Mesrouze; Gustavo Aguilar; Marco Meyerhofer; Fedir Bokhovchuk; Catherine Zimmermann; Patrizia Fontana; Alexandra Vissières; Hans Voshol; Dirk Erdmann; Markus Affolter; Patrick Chène
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.